DKF-MA102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DKF-MA102, covering 2024-07-08 to 2024-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer [Phase 3]